BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28960334)

  • 1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
    Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF;
    Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of corticosteroid allergy in Thailand.
    Wattanakrai P; Temnithikul B; Pootongkam S
    Dermatitis; 2010; 21(4):203-6. PubMed ID: 20646671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of contact allergy to corticosteroids in a Danish patient population.
    Svendsen SV; Bach RO; Mortz CG
    Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema].
    Vestergaard L; Andersen KE
    Ugeskr Laeger; 1997 Sep; 159(38):5662-6. PubMed ID: 9340873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact allergy to corticosteroids: Is the European baseline series sufficient?
    Svendsen SV; Bindslev-Jensen C; Mortz CG
    Contact Dermatitis; 2023 Oct; 89(4):277-283. PubMed ID: 37321366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for corticosteroid contact hypersensitivity.
    Boffa MJ; Wilkinson SM; Beck MH
    Contact Dermatitis; 1995 Sep; 33(3):149-51. PubMed ID: 8565453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid contact hypersensitivity screening in Singapore.
    Khoo BP; Leow YH; Ng SK; Goh CL
    Am J Contact Dermat; 1998 Jun; 9(2):87-91. PubMed ID: 9601908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact Allergy to Topical Mometasone Furoate Confirmed by Rechallenge and Patch Test.
    Tatu AL; Ionescu MA; Nwabudike LC
    Am J Ther; 2018; 25(4):e497-e498. PubMed ID: 28328785
    [No Abstract]   [Full Text] [Related]  

  • 13. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid contact allergy: an EECDRG multicentre study.
    Dooms-Goossens A; Andersen KE; Brandäo FM; Bruynzeel D; Burrows D; Camarasa J; Ducombs G; Frosch P; Hannuksela M; Lachapelle JM; Lahti A; Menné T; Wahlberg JE; Wilkinson JD
    Contact Dermatitis; 1996 Jul; 35(1):40-4. PubMed ID: 8896953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group.
    Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R
    Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact hypersensitivity to topical corticosteroids.
    Burden AD; Beck MH
    Br J Dermatol; 1992 Nov; 127(5):497-500. PubMed ID: 1467289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
    Gönül M; Gül U
    Contact Dermatitis; 2005 Aug; 53(2):67-70. PubMed ID: 16033397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.